Erythroplakia
8
0
3
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
25.0%
2 terminated out of 8 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer
Artificial Intelligence Based Program to Classify Oral Cavity Findings Based on Clinical Image Analysis
Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions
Intra and Extra Oral Inspection of Oral Mucosa
Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial
Treatment of Oral Premalignant Lesions With 5-ALA PDT